Christophe Piketty (C Piketty)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Physical Activity

Atopic Dermatitis

Placebo Controlled

Top Venues

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Pamela Guglielmini, Fatoumata Fofana, Carla Dias-Barbosa, Danielle Rodriguez, Ismail Budhiarso, Zarif K Jabbar-Lopez, Christophe Piketty, Margaret Vernon, Jorge Puelles
The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis. Dermatology and therapy (2023)
Shawn G Kwatra, Danielle Rodriguez, Carla Dias-Barbosa, Ismail Budhiarso, Fatoumata Fofana, Margaret Vernon, Sylvie Gabriel, Christophe Piketty, Jorge Puelles
Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis. Dermatology and therapy (2023)
Robert Sidbury, Sady Alpizar, Vivian Laquer, Sunil Dhawan, William Abramovits, Luca Loprete, Jayendar Kumar Krishnaswamy, Faiz Ahmad, Zarif Jabbar-Lopez, Christophe Piketty
Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents. Dermatology and therapy 12 (3) (2022)
S Ständer, G Yosipovitch, J-P Lacour, F J Legat, C Paul, Adam Reich, K Chaouche, F Ahmad, Christophe Piketty
Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (10) (2022)
Jonathan Ian Silverberg, Andreas Pinter, A Alavi, C Lynde, Jean-David Bouaziz, Andreas Wollenberg, D F Murrell, S Alpizar, V Laquer, K Chaouche, F Ahmad, J M Armstrong, Christophe Piketty
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)